Aire-dependent peripheral tissue antigen mRNAs in mTEC cells feature networking refractoriness to microRNA

Claudia Macedo1, Ernna H Oliveira1, Renata S Almeida1

  • 1Molecular Immunogenetics Group, Department of Genetics, School of Medicine of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, SP, Brazil.

Immunobiology
|September 16, 2014
PubMed

Insights

Downregulation of specific mRNA targets (PTA) in medullary thymic epithelial cells (mTECs) is linked to autoimmune diseases. This study identifies novel microRNAs (miRNAs) regulating these PTAs, revealing a new mechanism for self-tolerance control.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Loss of self-tolerance in autoimmune diseases is associated with downregulated PTA genes in mTECs.
  • The precise role of miRNAs in regulating PTA gene expression within mTECs remains unclear.

Purpose of the Study:

  • To investigate the differential expression of mRNAs and miRNAs in mTECs during the loss of self-tolerance.
  • To elucidate the regulatory network between miRNAs and PTA mRNAs in mTECs from autoimmune NOD mice compared to non-autoimmune BALB/c mice.

Main Methods:

  • Comparative analysis of mRNA and miRNA expression profiles in mTECs from NOD and BALB/c mice.
  • Construction of miRNA-mRNA interaction networks to identify key regulatory miRNAs and their PTA targets.
  • Assessment of the interaction refractoriness between miRNAs and known Aire-dependent PTAs.

Main Results:

  • Downregulation of a specific set of PTA mRNAs was observed in mTECs from autoimmune NOD mice.
  • Differential expression of several miRNAs was identified between NOD and BALB/c mice.
  • miRNA-mRNA interaction network analysis revealed controller miRNAs and predicted PTA mRNA targets, with Aire-dependent PTAs showing resistance to miRNA interactions.

Conclusions:

  • A novel regulatory mechanism involving miRNAs and PTA mRNAs in mTECs has been identified.
  • This mechanism may play a significant role in the maintenance and control of self-tolerance.
  • The refractoriness of Aire-dependent PTAs suggests a complex regulatory interplay in mTECs.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.8K
MicroRNAs01:22

MicroRNAs

9.8K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
24.2K